CUV 1.42% $13.90 clinuvel pharmaceuticals limited

Still Undervalued, page-3

  1. 90 Posts.
    lightbulb Created with Sketch. 1
    Absolutely. I should have added that given the low volume the stock will continue to be vulnerable to manipulation, and there could be a volatile period ahead.

    My sentiment is "buy" but I wish there was an option for "longterm buy" because that's far more accurate. I enjoy checking in everyday (especially on a day like this) but I'm looking a year or two ahead.

    Obviously a takeover offer would change everything. There's no rush for a big pharma to make an offer, they don't have to be the first, they just have to be the highest. If it's as derisked as many believe, then a number of companies will be running the numbers.

    I always figured an offer would come after steady income from the US, but maybe that's just wishful thinking.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.